PMVP PMV Pharmaceuticals, Inc. Forward P/S Multiple

pmvpharma.com (PMVP) - corporate logo

PMV Pharmaceuticals develops innovative protein restoration therapies for oncology, targeting the massive demand among patients with genetic mutations. The forward P/S metric helps quantitative analysts identify inflection points and assess drawdown risks, while shapes the current metric value. A robust network of independent component synthesis sites protects research from disruptions, maintaining high profitability.

PMVP (pmvpharma.com) Price to Expected Revenue Ratio history from 07/04/2022 to 11/14/2026

PMV Pharmaceuticals, Inc - analytical breakdowns and key metrics (PMVP)

- current price and projected stock value:
Stock Price PMV Pharmaceuticals, Inc.|PMVP - Analyst Target Range
- market capitalization data:
Market Capitalization PMV Pharmaceuticals, Inc|PMVP - Total Enterprise Value
- issuer book value statistics:
Accounting Value per Share PMV Pharmaceuticals|PMVP - Total Net Assets|Market Capitalization to Book Value Ratio pmvpharma.com|PMVP - Company Assets
- debt and liquidity data:
Total Debt to Capital PMV Pharmaceuticals|PMVP - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio PMV Pharmaceuticals|PMVP - Aggregate Debt Obligations|Debt to Book Value PMV Pharmaceuticals, Inc|PMVP - Amount of Long-Term Liabilities|Company Short-Term Debts PMV Pharmaceuticals|Quick Ratio pmvpharma.com
- net income and valuation multiples indicators:
PMVP - Company Net Income|Expected Profit PMV Pharmaceuticals|PMVP - Company Value to Net Income|Forward P/E Multiple PMV Pharma|PMVP - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PMV Pharmaceuticals, Inc|PMVP - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months PMV Pharmaceuticals|PMVP - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months pmvpharma.com|PMVP - Earnings per share trend in current year|Net earnings per share growth forecast for next year PMV Pharmaceuticals
- issuer revenue and sales details:
PMVP - Company Sales|Company Future Sales Volume PMV Pharmaceuticals, Inc.|PMVP - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple PMV Pharmaceuticals, Inc
Summary company analysis:PMV Pharmaceuticals, Inc. (PMVP)
Product sample of pmvpharma.com

PMV Pharmaceuticals is developing an innovative protein regeneration platform in oncology, establishing a foundation for strategic alliances with global pharma behemoths. The current forward P/S trend at aligns market capitalization with expected revenue, filtering out speculative noise and confirming the fundamental price stability through the lens of the company's future commercial successes.

Competing companies

Forward P/S Multiple GMAB (Genmab)|Projected Price to Revenue Exelixis Inc|Nuvalent Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Kymera Corp|IDYA (IDEAYA Biosciences) - Forward Price-to-Revenue Multiple|ELVN: Price to Expected Revenue Ratio|ORIC (ORIC Pharmaceuticals, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Relay Therapeutics Inc RLAY|Forward P/S Multiple NRIX|Tyra Corp - Market Cap to Projected Revenue|Verastem, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales GLUE|CGEM: Forward Price-to-Revenue Multiple|Immuneering Corp - Price to Expected Revenue Ratio|CCCC: Forward P/S Multiple|Black Diamond Therapeutics, Inc - Forward Price to Sales|RPTX (Repare Therapeutics) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Karyopharm KPTI|Price-to-Projected Revenue Ratio Propanc Biopharma Inc (PPCB)|BGMS (Bio Green Med Solution Inc.) - Forward Price to Sales|Forward P/S Multiple AADI (Aadi Bioscience, Inc.)|Forward P/S Multiple Aileron Therapeutics Inc ALRN|BPMC - Price-to-Projected Revenue Ratio|Future Price to Revenue GLYC|SWTX (SpringWorks Therapeutics, Inc.) - Forward Price-to-Revenue Multiple